SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U102. A total of 61 filers reported holding SYNTHETIC BIOLOGICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $31,000 | -22.5% | 131,000 | +4.0% | 0.01% | -16.7% |
| Q1 2018 | $40,000 | -37.5% | 126,000 | 0.0% | 0.01% | -40.0% |
| Q4 2017 | $64,000 | +30.6% | 126,000 | +142.3% | 0.01% | +25.0% |
| Q3 2017 | $49,000 | +69.0% | 52,000 | 0.0% | 0.01% | +60.0% |
| Q2 2017 | $29,000 | -63.3% | 52,000 | -58.7% | 0.01% | -64.3% |
| Q1 2017 | $79,000 | -17.7% | 126,000 | 0.0% | 0.01% | -17.6% |
| Q4 2016 | $96,000 | -55.8% | 126,000 | 0.0% | 0.02% | -56.4% |
| Q3 2016 | $217,000 | -4.4% | 126,000 | 0.0% | 0.04% | -9.3% |
| Q2 2016 | $227,000 | -23.6% | 126,000 | 0.0% | 0.04% | -27.1% |
| Q1 2016 | $297,000 | +75.7% | 126,000 | +70.3% | 0.06% | +78.8% |
| Q4 2015 | $169,000 | +0.6% | 74,000 | 0.0% | 0.03% | 0.0% |
| Q3 2015 | $168,000 | -20.4% | 74,000 | 0.0% | 0.03% | -13.2% |
| Q2 2015 | $211,000 | – | 74,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 13,238,268 | $6,726,000 | 0.58% |
| MSD Partners, L.P. | 4,118,402 | $2,092,000 | 0.11% |
| 683 Capital Management, LLC | 1,500,000 | $762,000 | 0.06% |
| Vivaldi Capital Management LP | 101,145 | $51,000 | 0.04% |
| Alyeska Investment Group, L.P. | 5,000,000 | $2,540,000 | 0.02% |
| BARD ASSOCIATES INC | 56,499 | $29,000 | 0.01% |
| FRANKLIN STREET ADVISORS INC /NC | 126,000 | $64,000 | 0.01% |
| Virtu Financial LLC | 299,577 | $152,000 | 0.01% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 46,981 | $24,000 | 0.01% |
| Stanley-Laman Group, Ltd. | 60,323 | $31,000 | 0.01% |